In infectious diseases, the concept of precision medicine – the right medicine, at the right dose, for the right patient, at the right time – can be applied in various ways including the analysis of an individual patient microbiome to predict disease or health outcomes as well as in the more precise monitoring of antimicrobial resistance of pathogens. Preventing and managing the emergence of antiretroviral drug resistance is a key component of worldwide efforts to reduce antimicrobial resistance. Additionally, while many studies have focused on the characterization of the gut bacterial microbiome (bacteriome), a better understanding of the microbiome impact on patient health will need to include evaluation of other human ecosystems including the fungal microbiome (mycobiome).
Bacteriome and Mycobiome Imbalance and Design of Precision Medicine and Nutrition
Mahmoud A. Ghannoum, PhD, EMBA, FIDSA,FAAM, University Hospitals Cleveland Medical
Objectives:
- Describe the gut Mycobiome and understand the interactions between the bacteriome and mycobiome and its consequences on health outcomes.
Duration: 0.75 hr
Recording Date: November 9, 2019
CME/CMLE credit: 0.75 hr
Last day to purchase course and CE claim credit: December 24, 2022
